Skip to content
Screener

Cardiff Oncology CRDF Q1 2026 earnings

Reported May 14, 2026 · Before market open

Revenue$41.0KMiss by $47.6K
EPS-$0.18Miss by $0.05
Revenue estimate$88.6K
EPS estimate-$0.13

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$67.2K
EPS estimate-$0.15

FAQ

When did Cardiff Oncology report Q1 2026 earnings?
Cardiff Oncology (CRDF) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Cardiff Oncology's Q1 2026 revenue and EPS?
Cardiff Oncology reported revenue of $41.0K and eps of $-0.18 for Q1 2026.
Did Cardiff Oncology beat estimates in Q1 2026?
Revenue missed the consensus estimate of $88.6K by $47.6K. EPS missed the consensus estimate of $-0.13 by $0.05.
How did Cardiff Oncology's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 62.4% from $109.0K a year earlier and eps grew 10.0% from $-0.20.
Where can I find Cardiff Oncology's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001213037-26-000013) and the 10-Q periodic report (0001213037-26-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.